Program Director: Emily F. Mason, M.D., Ph.D.
The Hematopathology Division was started in the early 1970's by Dr. Robert D. Collins. The primary focus of the program is to provide 1) state of the art diagnostic services that integrate morphologic, immunophenotypic, molecular genetic, and ultrastructural studies, 2) resident training in the basics of hematopathology, 3) fellowship training that emphasizes the development of academic hematopathologists, and 4) research opportunities with hematopathology faculty. Current areas of investigation include the molecular basis of leukemias and lymphomas, application of molecular and flow cytometric technology to the diagnosis of hematolymphoid neoplasms, the pathogenesis of myelodysplasia, and the role of extracellular matrix receptors in platelet/vascular biology, and the innate immune response. The division offers a one or two year ACGME accredited fellowship which emphasizes diagnostic hematopathology in the first year and research in the second year. Space is available in the divisional core laboratory and in the laboratories of independent investigators for both clinical/translational, as well as basic research projects. The diagnostic immunopathology and molecular genetics laboratories are an integral part of the division and provide opportunities for training and research for both residents and fellows.
The Hematopathology lab evaluates approximately over 5,400 Hematopathology cases including over 3,000 in-house bone marrows, over 1,100 consults and referrals, 550 in-house tissue biopsies, 1,000 body fluids and over 5,000 flow cytometry cases per year from Vanderbilt University Hospital and Monroe Carell Jr. Children's Hospital at Vanderbilt and an additional 900 morphology cases and 1,000 flow cytometry cases per year from the VA Tennessee Valley Healthcare System. Our group provides service for the Vanderbilt University Hospital, a 1000-bed tertiary adult care hospital, the VA Tennessee Valley Healthcare System, a 282-bed general purpose hospital, and Vanderbilt's state of the art 343-bed Monroe Carell Jr. Children's Hospital at Vanderbilt.
Goals and Objectives of the Program
Applications
Please note that the positions for 2025-2026 are filled.
For fellowships starting July 1, 2026, VUMC will be participating in the Hematopathology Fellowship Match. Interviews will begin in January 2025, with Match Day taking place on April 30, 2025.
Interested applicants should submit a cover letter, Vanderbilt application*, CV, personal statement, three letters of recommendation, and ECFMG certificate (if applicable) to:
Holly Spann, Administrative Assistant
Vanderbilt University School of Medicine
Department of Pathology, Microbiology and Immunology
Hematopathology Division
Nashville, TN 37228
*Application and pertinent information can be found under Graduate Medical Education